Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Progressive resistance therapy is not the best way to rehabilitate deficits due to multiple sclerosis: No.
Physical and mental health comorbidity is common in people with multiple sclerosis: nationally representative cross-sectional population database analysis.
"Putting One Foot in Front of the Other": A Qualitative Study of Emotional Experiences and Help-Seeking in Women with Multiple Sclerosis.
Combined EPR and Molecular Modeling Study of PPI Dendrimers Interacting with Copper Ions: Effect of Generation and Maltose Decoration.
Multiple sclerosis: a primary care perspective.
Confronting the diagnosis of multiple sclerosis: a qualitative study of patient experiences.
Association between pathological and MRI findings in multiple sclerosis.
Modelling and Prediction of 25-Hydroxyvitamin D Levels in Norwegian Relapsing-Remitting Multiple Sclerosis Patients.
Transverse myelitis.
No Regional Gray Matter Atrophy Differences between Pediatric- and Adult-Onset Relapsing-Remitting Multiple Sclerosis.
Reductions in neuronal peroxisomes in multiple sclerosis grey matter.
Impact of Autologous Mesenchymal Stem Cell Infusion on Neuromyelitis Optica Spectrum Disorder: A Pilot, 2-Year Observational Study.
Prescriber utilization of dalfampridine extended release tablets in multiple sclerosis: a retrospective pharmacy and medical claims analysis.
Interpretation and visualization of non-linear data fusion in kernel space: study on metabolomic characterization of progression of multiple sclerosis.
Fingolimod reduces recurrence of disease activity after natalizumab withdrawal in multiple sclerosis.
Behçet's Disease Presenting with Acute Transverse Myelitis: MRI Findings and Review of the Nosology. A Case Report.
Long-term TENS treatment decreases cortical motor representation in multiple sclerosis.
Targeting Innate Receptors with MIS416 Reshapes Th Responses and Suppresses CNS Disease in a Mouse Model of Multiple Sclerosis.
1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of T(H)17 cells to protect against experimental autoimmune encephalomyelitis.
Multiple Sclerosis: Validation of MR Imaging for Quantification and Detection of Iron.
Cannabinoid pharmacology: the first 66 years.
Successful desensitization to natalizumab in a skin test--positive patient: a case report.
An Empirical Investigation of a Biopsychosocial Model of Pain in Multiple Sclerosis.
Cognitive impairment as unusual first manifestation in late-onset relapsing-remitting multiple sclerosis.
Epitope-specific immune tolerization ameliorates experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
137
138
139
140
141
142
143
144
145
…
next ›
last »